Introduction {#s1}
============

Retinitis pigmentosa (RP \[MIM 268000\]) is a highly heterogeneous genetic disease characterized by night blindness and visual field constriction leading to severe visual impairment. The disease appears with different modes of inheritance including autosomal recessive (ar), autosomal dominant (ad), and X-linked, and currently over half of cases are isolated in Japan.

To date, 53 causative genes and 7 loci of RP have been identified (<http://www.sph.uth.tmc.edu/Retnet/>), including the eyes shut homolog (*EYS*) gene encoding an ortholog of *Drosophila* spacemaker (spam), a protein essential for photoreceptor morphology. *EYS* spans over 2 Mb, making it one of the largest known genes expressed in the human eye [@pone.0031036-AbdElAziz1], [@pone.0031036-Collin1]. *EYS* gene mutations, primarily truncating and some missense mutations, have been detected in arRP families of different ancestral origin and have reported to account for 5--16% of arRP [@pone.0031036-AbdElAziz2]--[@pone.0031036-Littink1]. Most gene mutations (e.g., *RHO*, *PRPH2*, *PRPF31*, *RP1*, and *IMPDH1*) have been found in Japanese patients with adRP, with few reports describing mutations in arRP [@pone.0031036-Hotta1], [@pone.0031036-Jin1]. Therefore, the genes causing arRP in most Japanese families have yet to be identified.

In this study, we screened all *EYS* gene exons in 100 unrelated Japanese RP patients. We found 2 novel truncating *EYS* gene mutations that were surprisingly related to 16% of Japanese arRP patients, but were not detected in Japanese patients with either adRP or Leber\'s congenital amaurosis (LCA \[MIM204000\], the earliest onset and most severe form of hereditary retinal dystrophy with several clinical features overlapping with those of RP). Additionally, these mutations were also detected in 9% of Korean arRP patients.

Methods {#s2}
=======

Patients and clinical evaluation {#s2a}
--------------------------------

We screened all *EYS* gene exons in 100 unrelated Japanese RP patients with no systemic manifestations, excluding families with obvious autosomal dominant inheritance. Some pedigrees showed a pattern compatible with the recessive mode of inheritance; the other patients were considered isolated cases. In addition, 200 unrelated and non-RP Japanese individuals were screened as controls to evaluate the frequency of the mutations found in the patient samples. We also screened a part of *EYS* gene exons 26 and 44 in 19 unrelated Japanese adRP patients, 28 unrelated Japanese LCA patients, and 32 unrelated Korean arRP patients. The 19 Japanese adRP patients had already been screened for some principal adRP-causing genes, but the pathogenic mutations have not yet been detected. Examples of the screening list for adRP-causing genes and targeted exons include exon 3 and 4 in *RP1*; exon 1, 2, 3, 4, and 5 in *RHO*; exon 1, 2, and 3 in *PRPH2*; exon 2, 3, and 4 in *CRX*; exon 11 in *PRPF3*; exon 10, 11, and 12 in *IMPDH1*; exon 2 in *NRL*; exon 43 in *PRPF8*; exon 1 and 2 in *ROM1*; exon 5 and 6 in *RP9*; exon 2, 3, 5, 6, 7, 8, 11, and 12 in *PRPF31*; exon 11 and 15 in *SEMA4A*; exon 1 in *CA4*; exon 3 in *GUCA1B*; exon 3 in *SP4*; and exon 3 in *TOPORS*.

Japanese RP patients were examined either at the Department of Ophthalmology, Hamamatsu University Hospital in Hamamatsu (by YH), Department of Ophthalmology, Kobe City Medical Center General Hospital in Kobe (by MT), or Department of Ophthalmology, Nagoya University Hospital in Nagoya (by MK). Patients\' origin varied widely, from the Tokyo to Osaka areas in Japan. Japanese LCA patients were examined at the Department of Ophthalmology and Laboratory of Cell Biology, National Center for Child Health and Development in Tokyo (by NA). LCA patients\' origin varied widely, from all over Japan except the Okinawa islands. Meanwhile, Korean RP patients were examined at the Department of Ophthalmology, Kyungpook National University Hospital in Daegu (by ITK). The Korean patients\' origin varied widely, from Daegu to Yeongju and Pohang areas in Gyeongsangbuk-do, Korea. A full ophthalmic examination was performed. Clinical diagnosis for RP was based on visual field, fundus examination, and electroretinogram findings, and clinical diagnosis for LCA was based on fundus examination and electroretinogram findings.

Ethics statements {#s2b}
-----------------

This study was approved by the Institutional Review Board for Human Genetic and Genome Research at the 6 participating institutions (Hamamatsu University School of Medicine, RIKEN Center for Developmental Biology, Nagoya University Graduate School of Medicine, National Center for Child Health and Development, Chiba University Graduate School of Medicine, and Kyungpook National University Hospital), and its procedures conformed to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all participants before molecular genetic studies.

Mutation analysis {#s2c}
-----------------

Genomic DNA in Japanese samples was extracted from the peripheral lymphocytes using standard procedures. In Korean samples, whole blood samples were collected on FTA cards (GE Healthcare). Blood samples were spotted onto the cards and air-dried for 1 h at room temperature. For polymerase chain reaction (PCR) amplification, a 1.2-mm disk was punched from a dried blood spot using a Harris micro-punch tool (GE Healthcare) and processed according to the manufacturer\'s instructions. PCR was performed using the KOD -Plus- ver. 2 PCR kit (Toyobo) with the primer sets described in [Table S1](#pone.0031036.s001){ref-type="supplementary-material"} for 35 cycles of 98°C for 10 s, 60°C for 30 s, and 68°C for 1 min in an automated thermal cycler (GeneAmp PCR System 9700; Applied Biosystems). PCR products were purified with Wizard SV Gel and PCR Clean-up System (Promega) or treated with Exonuclease I and Antarctic Phosphatase (New England Biolabs). Direct sequencing was performed using the BigDye Terminator v3.1 Cycle Sequencing Kit on an ABI3100 autosequencer (Applied Biosystems). For Japanese arRP patients, all 44 exons, including 3 non-coding exons (exons 1--3) that cover the 5′ untranslated region and 41 coding exons (exons 4--44), were analyzed in both sense and antisense directions. For Japanese adRP and LCA patients, and Korean arRP patients, parts of exons 26 and 44 were analyzed ([Table S1](#pone.0031036.s001){ref-type="supplementary-material"}).

Assessment of pathogenicity {#s2d}
---------------------------

A sequence variant was considered pathogenic if it represented a truncating mutation (nonsense or frameshift), large-scale deletion mutation, or missense mutation affecting a conserved amino acid residue and did not appear in control samples (number of alleles studied ≤400) and/or in a public SNP database (<http://www.ncbi.nlm.nih.gov/projects/SNP/>). Particularly, missense mutations were considered pathogenic if found together with a second variant, especially if it was truncating. As reference data, we employed 4 computational algorithms to evaluate the pathogenicity of missense mutations: SIFT (<http://sift.jcvi.org/www/SIFT_seq_submit2.html>), PolyPhen2 (<http://genetics.bwh.harvard.edu/pph2/>), PMut (<http://mmb.pcb.ub.es/PMut/>), and SNAP (<http://rostlab.org/services/snap/>).

Results {#s3}
=======

Mutation analysis {#s3a}
-----------------

Mutation analysis of *EYS* in 100 unrelated Japanese patients revealed 7 very likely pathogenic mutations in 18 patients (18%). Of these 18 patients, a second mutant allele could not be detected in 9 patients. The very likely pathogenic mutations consisted of 3 truncating mutations, 1 deletion mutation, 2 missense mutations, and 1 previously described mutation ([Fig. 1](#pone-0031036-g001){ref-type="fig"}, [Table 1](#pone-0031036-t001){ref-type="table"}, and [Table 2](#pone-0031036-t002){ref-type="table"}). In addition, we also identified 6 possible pathogenic mutations in 8 separate patients ([Table 1](#pone-0031036-t001){ref-type="table"} and [Table 2](#pone-0031036-t002){ref-type="table"}).

![Electropherograms of the 6 likely pathogenic *EYS* mutations.\
Partial sequence of the *EYS* gene showing the normal control sequences (A-1 through F-1), heterozygous mutation sequences (A-2 through F-2), and homozygous mutation sequences (A-3 and C-3). Deduced amino acids are indicated under the sequence trace. The mutation location is indicated either by an arrow (for a nucleotide change) or a horizontal line (to show 2 nucleotides between which the insertion occurred). (A) c.4957_4958insA; p.S1653KfsX2 (Exon 26), (B) c.6557G\>A; p.G2186E (Exon 32), (C) c.8868C\>A; p.Y2956X (Exon 44), (D) c.8351T\>G; p.L2784R (Exon 44), (E) c.7793G\>A; p.G2598D (Exon 40), (F) c.2522_2523insA; p.Y841X (Exon 16).](pone.0031036.g001){#pone-0031036-g001}

10.1371/journal.pone.0031036.t001

###### Mutation spectrum of the *EYS* gene in Japanese families.

![](pone.0031036.t001){#pone-0031036-t001-1}

  Family ID                                                                          Nucleotide change                      Predicted effect                 Domain[a](#nt102){ref-type="table-fn"}     Location in gene        Type of change                                       Reference
  -------------------------------------------------------------------------- --------------------------------- ------------------------------------------- ------------------------------------------- ------------------ --------------------------- -----------------------------------------------------------------------
  Families with very likely pathogenic mutations and both alleles affected                                                                                                                                                                            
  RP3H[b](#nt103){ref-type="table-fn"}                                        c.4957_4958insA/c.4957_4958insA           p.S1653KfsX2/p.S1653KfsX2           Close to coiled-coil/Close to coiled-coil   Exon 26/Exon 26           Homozygous                                        This study
  RP48K[b](#nt103){ref-type="table-fn"}                                       c.4957_4958insA/c.4957_4958insA           p.S1653KfsX2/p.S1653KfsX2           Close to coiled-coil/Close to coiled-coil   Exon 26/Exon 26           Homozygous                                        This study
  RP54K                                                                       c.4957_4958insA/c.4957_4958insA           p.S1653KfsX2/p.S1653KfsX2           Close to coiled-coil/Close to coiled-coil   Exon 26/Exon 26           Homozygous                                        This study
  RP44K                                                                         c.4957_4958insA/c.6557G\>A                p.S1653KfsX2/p.G2186E                  Close to coiled-coil/Laminin G         Exon 26/Exon 32    Heterozygous/Heterozygous   This study/Abd El-Aziz et al., 2010; Littink et al., 2010; This study
  RP56K[b](#nt103){ref-type="table-fn"}                                         c.4957_4958insA/c.8351T\>G                p.S1653KfsX2/p.L2784R                  Close to coiled-coil/Laminin G         Exon 26/Exon 44      Compound Heterozygous                                  This study
  RP87N                                                                         c.4957_4958insA/c.7793G\>A                p.S1653KfsX2/p.G2598D              Close to coiled-coil/Close to Laminin G    Exon 26/Exon 40    Heterozygous/Heterozygous                                This study
  RP81K[b](#nt103){ref-type="table-fn"}                                         c.2522_2523insA/c.6557G\>A                  p.Y841X/p.G2186E                              EGF/Laminin G                 Exon 16/Exon 32      Compound Heterozygous     This study/Abd El-Aziz et al., 2010; Littink et al., 2010; This study
  RP21H                                                                       deletion exon32/deletion exon32   p.D2142_S2191delinsG/p.D2142_S2191delinsG              Laminin G/Laminin G              Exon 32/Exon 32           Homozygous                                        This study
  RP35K                                                                            c.8868C\>A/c.8868C\>A                    p.Y2956X/p.Y2956X                                EGF/EGF                    Exon 44/Exon 44           Homozygous                                        This study
  Families with single very likely pathogenic mutations                                                                                                                                                                                               
  RP1H                                                                                c.4957_4958insA                         p.S1653KfsX2                            Close to coiled-coil                  Exon 26              Heterozygous                                       This study
  RP6H                                                                                c.4957_4958insA                         p.S1653KfsX2                            Close to coiled-coil                  Exon 26              Heterozygous                                       This study
  RP12H                                                                               c.4957_4958insA                         p.S1653KfsX2                            Close to coiled-coil                  Exon 26              Heterozygous                                       This study
  RP51K                                                                               c.4957_4958insA                         p.S1653KfsX2                            Close to coiled-coil                  Exon 26              Heterozygous                                       This study
  RP96H                                                                               c.4957_4958insA                         p.S1653KfsX2                            Close to coiled-coil                  Exon 26              Heterozygous                                       This study
  RP100N                                                                              c.4957_4958insA                         p.S1653KfsX2                            Close to coiled-coil                  Exon 26              Heterozygous                                       This study
  RP8H                                                                                  c.8868C\>A                              p.Y2956X                                       EGF                          Exon 44              Heterozygous                                       This study
  RP25H                                                                                 c.8868C\>A                              p.Y2956X                                       EGF                          Exon 44              Heterozygous                                       This study
  RP80K[b](#nt103){ref-type="table-fn"}                                                 c.8868C\>A                              p.Y2956X                                       EGF                          Exon 44              Heterozygous                                       This study
  Families with single possible pathogenic mutations                                                                                                                                                                                                  
  RP4H                                                                                  c.9272T\>C                              p.I3091T                                    Laminin G                       Exon 44              Heterozygous                                       This study
  RP9H                                                                                  c.8875C\>A                              p.L2959M                                       EGF                          Exon 44              Heterozygous                                       This study
  RP49K                                                                                 c.9272T\>C                              p.I3091T                                    Laminin G                       Exon 44              Heterozygous                                       This study
  RP53K                                                                                 c.5884A\>G                              p.T1962A                                    Laminin G                       Exon 28              Heterozygous                                       This study
  RP55K                                                                                 c.9272T\>C                              p.I3091T                                    Laminin G                       Exon 44              Heterozygous                                       This study
  RP74K                                                                                 c.5404C\>T                              p.L1802F                               Close to Laminin G                   Exon 26              Heterozygous                                       This study
  RP79K                                                                                  c.77G\>A                                p.R26Q                       Close to signal peptide cleavage site          Exon 4              Heterozygous                                       This study
  RP83K                                                                                 c.2923T\>C                               p.C975R                                       EGF                          Exon 19              Heterozygous                                       This study

Nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence FM209056, according to the nomenclature recommended by the Human Genome Variation Society ([www.hgvs.org/mutnomen](http://www.hgvs.org/mutnomen)). The initiation codon is codon 1. None of these 13 mutations were found in the Japanese controls.

EYS has a signal peptide, a putative coiled-coil, 29 EGF, and 5 Laminin G domains. See [Fig. 3](#pone-0031036-g003){ref-type="fig"}.

Segregation analysis has been performed. See [Fig. 2](#pone-0031036-g002){ref-type="fig"}.

In RP56K and RP81K, 2 pathogenic alleles were considered to be on different chromosomes (compound heterozygous). See [Fig. 2](#pone-0031036-g002){ref-type="fig"}.

10.1371/journal.pone.0031036.t002

###### Summary of the very likely and possible pathogenic mutations identified in 100 Japanese arRP patients.

![](pone.0031036.t002){#pone-0031036-t002-2}

                                                                                                                                                                                      Allele frequency                                                                                                                                                                       Computational prediction[c](#nt107){ref-type="table-fn"}                                                                 
  -------------------------------------- --------------- ------------------ ---------------------- --------- --------------------------------------- --------------------- --------------------------------------- -------- ---------------------------------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------- --------------------------- ------------------- -------------- -------------
  **Very likely pathogenic mutations**    **Insertion**   c.2522_2523insA          p.Y841X          Exon 16                    EGF                      not applicable                      0/400                   1/200                                         RP81K                                                                 This study                                                   Japanese                                                                                         
                                                          c.4957_4958insA        p.S1653KfsX2       Exon 26           Close to coiled-coil              not applicable                      0/400                   15/200   RP1H, RP3H, RP6H, RP12H, RP48K, RP51K, RP54K, RP44K, RP56K, RP87N, RP96H, RP100N                           This study                                                   Japanese                                                                                         
                                          **Nonsense**       c.8868C\>A            p.Y2956X         Exon 44                    EGF                      not applicable                      0/400                   5/200                               RP8H, RP25H, RP35K, RP80K                                                       This study                                                   Japanese                                                                                         
                                          **Deletion**    Deletion exon 32   p.D2142_S2191delinsG   Exon 32                 Laminin G                   not applicable      0/200[d](#nt108){ref-type="table-fn"}   2/200                                         RP21H                                                                 This study                                                   Japanese                                                                                         
                                          **Missense**       c.6557G\>A            p.G2186E         Exon 32                 Laminin G                 G/G/G/G/G/-/-/-/-/-                   0/400                   2/200                                      RP44K, RP81K                                     Abd El-Aziz et al., 2010; Littink et al., 2010; This study           Chinese, South Korean/American, Japanese                                       Probably damaging   Pathological   Non-neutral
                                                             c.7793G\>A            p.G2598D         Exon 40            Close to Laminin G             G/G/G/-/-/-/-/G/I/T                   0/400                   1/200                                         RP87N                                                                 This study                                                   Japanese                                                       Probably damaging                  Non-neutral
                                                             c.8351T\>G            p.L2784R         Exon 44                 Laminin G                 L/L/L/L/L/L/L/L/L/G                   0/400                   1/200                                         RP56K                                                                 This study                                                   Japanese                                                       Probably damaging                  Non-neutral
  **Possible pathogenic mutations**       **Missense**        c.77G\>A              p.R26Q          Exon 4    Close to signal peptide cleavage site   R/R/R/K/K/-/-/-/-/-                   0/400                   1/200                                         RP79K                                                                 This study                                                   Japanese                           Affected protein function                       Pathological  
                                                             c.2923T\>C            p.C975R          Exon 19                    EGF                    C/C/C/-/-/-/-/-/-/-                   0/400                   1/200                                         RP83K                                                                 This study                                                   Japanese                                                       Possibly damaging   Pathological   Non-neutral
                                                             c.5404C\>T            p.L1802F         Exon 26            Close to Laminin G             L/L/L/-/-/-/-/-/-/-                   0/400                   1/200                                         RP74K                                                                 This study                                                   Japanese                                                       Possibly damaging                 
                                                             c.5884A\>G            p.T1962A         Exon 28                 Laminin G                 T/T/T/T/-/-/-/-/-/-                   0/400                   1/200                                         RP53K                                                                 This study                                                   Japanese                                                       Possibly damaging                 
                                                             c.8875C\>A            p.L2959M         Exon 44                    EGF                    L/L/L/L/L/L/A/V/-/S                   0/400                   1/200                                          RP9H                                                                 This study                                                   Japanese                                                       Possibly damaging                 
                                                             c.9272T\>C            p.I3091T         Exon 44                 Laminin G                 I/I/I/I/I/I/I/I/I/L                   0/400                   3/200                                   RP4H, RP49K, RP55K                                                          This study                                                   Japanese                           Affected protein function   Probably damaging                 

EYS contains a signal peptide, a putative coiled-coil, 29 EGF, and 5 laminin G domains. See [Fig. 3](#pone-0031036-g003){ref-type="fig"}.

hu/o/m/ho/d/op/p/c/z/dr denotes Human/Orangutan/Marmoset/Horse/Dog/Opossum/Platypus/Chicken/Zebrafish/Drosophila EYS orthologs, respectively. The hyphen (-) indicates that genomic sequence of corresponding region in the species was reported to be unknown [@pone.0031036-Barragn1].

SIFT, PolyPhen2 (only the HumDiv data are shown), PMut, and SNAP were used as reference data to evaluate the pathogenicity of the missense mutations. c.77G\>A, c.2923T\>C, c.7793G\>A, c.8351T\>G, and c.9272T\>C were predicted to be pathogenic by a number of different computational prediction programs. In addition, the c.6557G\>A mutation, which had been previously reported as disease causing, was classified as pathogenic by the PolyPhen2, PMut, and SNAP programs.

Homozygous exon 32 deletion mutation was not detected in 200 controls.

A novel truncating insertion, c.4957_4958insA, was detected in 12 patients and accounted for 15 of the 35 mutated alleles detected (42.9%) ([Table 1](#pone-0031036-t001){ref-type="table"} and [Table 2](#pone-0031036-t002){ref-type="table"}). Three patients were homozygous for the c.4957_4958insA mutation, and the other 9 patients were heterozygous. Of the latter, 3 patients showed the second mutation while 6 did not. This insertion creates a frameshift mutation that predicts a premature stop at codon 1654 (p.S1653KfsX2). A novel truncating nonsense mutation c.8868C\>A (p.Y2956X) was identified in 4 patients and accounted for 5 of the 35 mutated alleles detected (14.3%). Thus, these 2 novel truncating mutations were identified in 16 separate patients, resulting in a very high frequency of the 2 mutations in Japanese arRP patients.

Families with very likely pathogenic mutations and both alleles affected {#s3b}
------------------------------------------------------------------------

Nine of the 18 patients bearing very likely pathogenic mutations appeared to have both alleles affected, suggesting that they received one mutated allele from each unaffected parent ([Table 1](#pone-0031036-t001){ref-type="table"} and [Table 2](#pone-0031036-t002){ref-type="table"}). In 4 patients (RP3H, RP48K, RP56K, and RP81K), segregation analysis was performed, and the 2 pathogenic alleles were considered to be on different chromosomes ([Fig. 2](#pone-0031036-g002){ref-type="fig"}).

1.  In RP3H, proband (II-6) was homozygous for c.4957_4958insA. The mutation co-segregated with the phenotype: the unaffected brother (II-4) demonstrated wild-type alleles, while the affected brother (II-5) was homozygous for the mutation.

2.  In RP48K, proband (II-1) was homozygous for c.4957_4958insA. The unaffected brother (II-2) was heterozygous for the mutation.

3.  In RP56K, proband (II-1) was compound heterozygous for c.4957_4958insA and missense mutation c.8351T\>G (p.L2784R). The mutation co-segregated with the phenotype: the affected brother (II-2) also showed both mutations, while the unaffected brother (II-3) was heterozygous for c.4957_4958insA.

4.  In RP81K, proband (II-5) was compound heterozygous for truncating insertion c.2522_2523insA (p.Y841X) and missense mutation c.6557G\>A (p.G2186E). This insertion results in premature termination of the encoded protein at codon 841 (p.Y841X). Missense mutation c.6557G\>A has been previously reported as disease causing in one Korean/American and one Chinese patient [@pone.0031036-AbdElAziz2], [@pone.0031036-Littink1]. The unaffected mother (I-2) was heterozygous for c.2522_2523insA, while the unaffected sister (II-6) was heterozygous for c.6557G\>A.

![Pedigrees of the families that was available for mutation analysis.\
Below the individuals, genotypes are presented for either p.S1653KfsX2 (M1), p.L2784R (M2), p.Y2956X (M3), p.Y841X (M4), or p.G2186E (M5) detected to segregate with RP. M1/M1 represents homozygous mutation. M1/+ indicates heterozygous carriers, +/+ indicates individuals carrying 2 wild-type alleles, whereas M1/M2 represents individuals presenting both mutations as compound heterozygous. Square boxes indicate men, circles denote women, and affected individuals are pointed out by a black symbol. Slashed symbols indicate deceased individuals. The probands are indicated with an arrow. NA denotes unavailable DNA samples.](pone.0031036.g002){#pone-0031036-g002}

For the other patients, segregation analysis could not be performed due to difficulties in collecting samples from the families of patients ([Table 1](#pone-0031036-t001){ref-type="table"}). RP54K and RP35K were homozygous for truncating mutation c.4957_4958insA and c.8868C\>A, respectively. RP21H was homozygous for deletion in exon 32, an in-frame deletion that results in the replacement of amino acids from D2142 to S2191 with G2142 (p.D2142_S2191delinsG) and disrupts the second laminin G domain ([Fig. 3](#pone-0031036-g003){ref-type="fig"}). RP44K and RP87N were heterozygous for truncating and missense mutations, c.4957_4958insA/c.6657G\>A (p.G2186E) and c.4957_4958insA/c.7793T\>G (p.G2598D), respectively. None of these 7 very likely pathogenic mutations were found in the Japanese controls.

![Predicted domain structure and distribution of identified *EYS* mutations.\
SMART (<http://smart.embl-heidelberg.de/>) and Pfam (<http://pfam.sanger.ac.uk/>) were used to search protein functional domains. A coiled-coil domain identified by Barragán et al. (2010) between the EGF-like domain and laminin G domain was also indicated. Novel very likely pathogenic mutations, novel possible pathogenic mutations, and a previously described mutation are shown in bold, normal, and italic type, respectively. Six out of 9 missense mutations were found in the EGF or laminin G domains. Furthermore, 7 were located in the latter half of the protein between the putative coiled-coil region and C-terminus.](pone.0031036.g003){#pone-0031036-g003}

Families with single novel very likely pathogenic mutations {#s3c}
-----------------------------------------------------------

The rest of the patients comprising the group with very likely pathogenic mutations presented only single truncating mutations ([Table 1](#pone-0031036-t001){ref-type="table"} and [Table 2](#pone-0031036-t002){ref-type="table"}). RP1H, RP6H, RP12H, RP51H, RP96H, and RP100N were heterozygous for c.4957_4958insA. RP8H, RP25H, and RP80K were heterozygous for c.8868C\>A. Segregation analysis was performed in patient RP80K. The unaffected father (I-1) demonstrated wild-type alleles, and the unaffected mother (I-2) was heterozygous for the mutation ([Fig. 2](#pone-0031036-g002){ref-type="fig"}). In RP96H, we found very likely pathogenic missense mutation c.8923T\>C (p.F2975L), which was not detected in any of the 400 control alleles. However, as c.8923T\>C has been described as rs79036642 in the dbSNP database, it was assigned to the group of possible non-pathogenic sequence alterations ([Table 3](#pone-0031036-t003){ref-type="table"}).

10.1371/journal.pone.0031036.t003

###### Summary of the possible non-pathogenic sequence alterations in the *EYS* gene identified in this study.

![](pone.0031036.t003){#pone-0031036-t003-3}

  Gene exon       Nucleotide change       Predicted effect   Conservation in hu/o/m/ho/d/op/p/c/z/dr[a](#nt110){ref-type="table-fn"}   Patient frequency   Control frequency     SNP ID                                             Reference
  ----------- -------------------------- ------------------ ------------------------------------------------------------------------- ------------------- ------------------- ------------- ------------------------------------------------------------------------------------------
  Exon 1              c.-500A\>G                                                                                                            13/200                              rs1490127                                    Abd El-Aziz et al., 2010
  Exon 4              c.334G\>A               p.V112I                                  V/I/I/I/I/I/-/-/-/E                                   1/200               0/192         rs112609906  
                      c.359C\>T               p.T120M                                  T/T/T/T/T/A/-/-/-/I                                  60/200                             rs12193967                          Audo et al., 2010; Abd El-Aziz et al., 2010
                   c.525_527delGGA           p.176delE                                 E/E/E/E/E/A/-/-/-/G                                   1/200               1/192                                                              This study
  Intron 5       c.863-23_863-22insTT                                                                                                       53/200                             rs34154043                                    Abd El-Aziz et al., 2010
                c.863-23_863-22insTTT                                                                                                       44/200                                                                                  This study
  Exon 6              c.1005G\>T              p.E335D                                  E/E/D/-/-/-/-/-/-/-                                   3/200                             rs80095433   
  Exon 7              c.1146T\>C              p.N382N                                  N/N/T/-/-/-/-/-/-/-                                  97/200                              rs974110                           Audo et al., 2010; Abd El-Aziz et al., 2010
  Intron 8           c.1300-3C\>T                                                                                                           117/200                             rs1936439                          Audo et al., 2010; Abd El-Aziz et al., 2010
  Exon 9              c.1382G\>A              p.C461Y                                  C/C/Y/-/-/-/-/-/-/-                                   8/200               4/192         rs76754818                                      Littink et al., 2010
  Intron 9          c.1599+96A\>C                                                                                                           200/200                             rs1502963                                    Abd El-Aziz et al., 2010
  Intron 10         c.1600-38G\>A                                                                                                           12/200                              rs1502965                                    Abd El-Aziz et al., 2010
  Exon 11             c.1712A\>G              p.Q571R                                  Q/Q/Q/-/-/-/-/-/-/-                                  26/200                             rs61753610                                      Audo I et al., 2010
  Exon 12             c.1809C\>T              p.V603V                                  V/V/V/-/-/-/-/-/-/-                                  178/200                             rs9345601                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.1891G\>A              p.G631S                                  G/S/E/C/C/-/-/-/-/-                                  178/200                             rs9342464                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.1922A\>T              p.E641V                                  E/E/E/E/E/-/-/-/-/-                                  18/200                             rs17411795                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.1985G\>T              p.R662M                                  R/R/R/S/S/-/-/-/-/-                                   8/200               3/96                                                               This study
  Intron 12      c.2023+6_2023+7insT                                                                                                        175/200                            rs67504324   
                    c.2024-14C\>T                                                                                                            3/200                             rs45628235   
  Intron 15         c.2382-26C\>G                                                                                                           106/200                             rs9445437   
  Exon 16             c.2490T\>C              p.P830P                                  P/P/P/P/P/P/P/Q/P/-                                   2/200               1/392                                                              This study
                      c.2528G\>A              p.G843E                                  G/G/G/G/G/G/G/G/A/G                                  16/200               9/192         rs74419361   
                      c.2555T\>C              p.L852P                                  L/P/P/-/S/P/S/P/-/E                                  106/200                             rs9294631                          Audo et al., 2010; Abd El-Aziz et al., 2010
  Intron 18    c.2846+52_2846+53insTAAT                                                                                                     120/200                            rs66504228                                    Abd El-Aziz et al., 2010
                    c.2847-24C\>T                                                                                                           178/200                             rs7743515   
  Exon 19             c.2980C\>G              p.P994A                                  P/P/P/-/-/-/-/-/-/-                                   3/200               2/192                                                              This study
  Intron 22          c.3444-5C\>T                                                                                                           69/200                              rs9445051                          Audo et al., 2010; Abd El-Aziz et al., 2010
  Intron 23         c.3568+60delA                                                                                                            1/200                                                                                  This study
  Exon 25             c.3787A\>G              p.I1263V                                 I/V/V/V/V/-/-/-/-/I                                  36/200                             rs17404123                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.3809T\>G              p.V1270G                                 V/V/V/V/V/-/-/-/-/P                                   1/200               1/192                                                              This study
  Intron 25      c.3877+17_22delAGATA                                                                                                       36/200                                                                           Barragán I et al., 2010
  Exon 26             c.3906C\>T              p.H1302H                                 H/H/H/H/H/-/-/-/-/S                                  10/200                             rs12663916                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.3936A\>G              p.T1312T                                 T/A/T/A/A/-/-/-/-/S                                  10/200                             rs12662610                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.3973C\>G              p.Q1325E                                 Q/E/K/K/K/-/-/-/-/S                                  12/200                             rs12663622                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4026C\>T              p.S1342S                                 S/S/S/S/S/-/-/-/-/A                                  10/200                             rs12663619                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4081A\>G              p.I1361V                                 I/I/T/V/V/-/-/-/-/S                                  12/200                             rs17403955                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4256T\>C              p.L1419S                                 L/S/S/S/S/L/S/V/Q/V                                  137/200                             rs624851                           Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4352T\>C              p.I1451T                                 I/T/T/K/K/-/-/-/-/T                                  13/200                             rs62415828                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4543C\>T              p.R1515W                                 R/R/R/R/R/-/-/-/-/H                                  36/200                             rs62415827                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4549A\>G              p.S1517G                                 S/G/D/T/T/-/-/-/-/H                                  36/200                             rs62415826                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.4593G\>A              p.E1531E                                 E/E/E/E/E/-/-/-/-/Q                                  36/200                             rs62415825                          Audo et al., 2010; Abd El-Aziz et al., 2010
                      c.5244A\>C              p.L1748F                                 L/L/L/L/L/-/-/-/-/F                                   8/200                             rs57312007                           Audo I et al., 2010; Littink et al., 2010
                      c.5617C\>G              p.L1873V                                 L/L/L/P/P/-/-/-/-/I                                  38/200                             rs16895517                                      Audo I et al., 2010
  Exon 27             c.5705A\>T              p.N1902I                                 N/N/N/N/N/P/-/R/-/A                                  90/200                              rs9353806                          Audo et al., 2010; Abd El-Aziz et al., 2010
  Intron 28         c.5928-35T\>C                                                                                                           118/200                             rs587278                                     Abd El-Aziz et al., 2010
  Intron 29         c.6078+68A\>G                                                                                                           81/200                             rs36133910                                    Abd El-Aziz et al., 2010
                 c.6079-4_6079-3delTC                                                                                                       87/200                             rs35395170                                      Audo I et al., 2010
  Intron 34         c.6834+61T\>G                                                                                                           60/200                             rs66502009                                    Abd El-Aziz et al., 2010
  Exon 35             c.6977G\>A              p.R2326Q                                 R/R/R/L/L/L/L/L/I/L                                  95/200                              rs4710457                          Audo et al., 2010; Abd El-Aziz et al., 2010
  Exon 37             c.7394C\>G              p.T2465S                                 T/T/T/T/T/T/T/T/S/F                                   8/200               2/176                                                              This study
  Exon 39             c.7666A\>T              p.S2556C                                 S/S/S/S/S/N/S/H/E/E                                  57/200                             rs66462731    Audo et al., 2010; Abd El-Aziz et al., 2010; Barragán et al., 2010; Littink et al., 2010
  Intron 41         c.8071+84T\>G                                                                                                           53/200                              rs4710257                                    Abd El-Aziz et al., 2010
  Exon 44             c.8923T\>C              p.F2975L                                 F/F/F/F/F/F/F/F/-/K                                   1/200               0/400         rs79036642   
                      c.9300A\>G              p.L3100L                                 L/L/L/L/L/L/L/L/V/I                                   4/200               2/192                                                              This study

Fifty-four sequence alterations were identified in 100 patients. These alterations were predicted to be non-pathogenic for various reasons. Some have been reported as polymorphisms in previous reports. Newly identified alterations within the exons, except for c.334G\>A and c.8923T\>C, were also found in the control chromosome. The hyphen (-) indicates that genomic sequence of corresponding region in the species was reported to be unknown [@pone.0031036-Barragn1].

hu/o/m/ho/d/op/p/c/z/dr denotes Human/Orangutan/Marmoset/Horse/Dog/Opossum/Platypus/Chicken/Zebrafish/Drosophila EYS orthologs, respectively.

Families with single novel possible pathogenic mutations {#s3d}
--------------------------------------------------------

A group of patients with possible pathogenic mutations had only single missense mutations ([Table 1](#pone-0031036-t001){ref-type="table"} and [Table 2](#pone-0031036-t002){ref-type="table"}). We report 6 novel missense mutations in 8 different patients ([Table 1](#pone-0031036-t001){ref-type="table"} and [Table 2](#pone-0031036-t002){ref-type="table"}), none of which were identified in the 400 Japanese control alleles. All amino acid residues affected by these mutations were compared with those encoded by orthologous genes of various vertebrates (orangutan, marmoset, horse, dog, opossum, platypus, chicken, and zebrafish) and *Drosophila* and found to be highly conserved across species ([Table 2](#pone-0031036-t002){ref-type="table"}). The novel missense mutation c.2923T\>C (p.C975R) was predicted to be pathogenic by 3 different computational prediction programs (PolyPhen2, PMut, and SNAP) ([Table 2](#pone-0031036-t002){ref-type="table"}). RP4H, RP49K, and RP55K were heterozygous for the same missense mutation c.9272T\>C (p.I3091T), which was predicted to be pathogenic by SIFT and PolyPhen2 programs ([Table 2](#pone-0031036-t002){ref-type="table"}). In addition, 54 possible non-pathogenic sequence alterations were found, of which 9 were previously unreported ([Table 3](#pone-0031036-t003){ref-type="table"}).

Screening of the 2 truncating mutations {#s3e}
---------------------------------------

We focused on 2 truncating mutations, c.4957_4958insA in exon 26 and c.8868C\>A in exon 44, which were identified in 16 separate Japanese arRP patients in this study. The frequency of the 2 mutations was very high in this Japanese arRP cohort. However, we did not detect the 2 mutations in 19 Japanese adRP patients and 28 LCA patients who were recruited and screened to evaluate the frequency of the mutations. We also recruited 32 unrelated Korean arRP patients and screened for the 2 *EYS* gene mutations. The c.4957_4958insA mutation was detected in 2 patients and accounted for 3 of 64 Korean patient alleles (4.7%). One patient was homozygous and the other was heterozygous. The c.8868C\>A mutation was identified in 1 patient and accounted for 1 of the 64 Korean patient alleles (1.6%).

Clinical findings {#s3f}
-----------------

Nine Japanese patients with very likely pathogenic *EYS* gene mutations in both alleles, 9 Japanese patients with single very likely pathogenic changes, and a Korean patient with homozygous c.4957_4958insA mutation demonstrated classic RP with mostly night blindness as the initial symptom, followed by gradual constriction of the visual field. The fundus displayed bone spicules increasing in density with age and attenuated retinal vessels. Electroretinogram responses were not detectable, consistent with severe generalized rod-cone dysfunction. The remaining visual field determined using Goldmann kinetic perimetry with V-4 target ranged from approximately 10° to 60° of the central and inferior visual fields, respectively, in a 74-year-old woman (RP100N) to complete blindness in a 54-year-old man (RP21H). No remarkable clinical difference was observed between 9 patients with very likely pathogenic *EYS* gene mutations in both alleles and 9 patients with single very likely pathogenic changes.

Discussion {#s4}
==========

This study is the first to analyze mutations in the *EYS* gene among Japanese arRP patients. We detected 67 sequence alterations in the *EYS* gene, of which 21 were novel. Of these, 7 were very likely pathogenic mutations, 6 were possibly pathogenic mutations, and 54 were possible non-pathogenic sequence alterations ([Table 1](#pone-0031036-t001){ref-type="table"}, [Table 2](#pone-0031036-t002){ref-type="table"}, and [Table 3](#pone-0031036-t003){ref-type="table"}).

Considering only the very likely pathogenic mutations, the minimum observed prevalence of distinct *EYS* gene mutations in our study is 18% (18/100, 9 patients with 2 very likely pathogenic mutations and 9 with only one such mutations). Additionally, if the possible pathogenic mutations are included in the prevalence estimation, prevalence increases to 26% (26/100, with 17 of 26 patients presenting single mutations). The estimated prevalence in our study may be extremely high compared with those in the previous studies [@pone.0031036-AbdElAziz2]--[@pone.0031036-Littink1]. Until recently, mutations in 34 genes have been associated with arRP (<http://www.sph.uth.tmc.edu/Retnet/>). The most frequently mutated gene is *USH2A*, accounting for approximately 7% of arRP cases [@pone.0031036-Rivolta1], [@pone.0031036-Seyedahmadi1], whereas most other genes contribute to only 1% to 2% of arRP cases [@pone.0031036-Hartong1]. The estimated prevalence of very likely and possible pathogenic mutations of the *EYS* gene in our study was 26%, suggesting its major involvement in the pathogenesis of arRP in the Japanese population.

We found that 16% of Japanese arRP patients displayed at least one c.4957_4958insA or c.8868C\>A mutation, which accounted for 57.1% (15+5/35) of the mutated alleles. Thus, these mutations seem to be frequent among Japanese arRP patients. Previous studies employing Indonesian, Pakistani, Chinese, Israeli, Spanish, French, British, Dutch, and Palestinian RP patient populations have not detected them [@pone.0031036-AbdElAziz2]--[@pone.0031036-Littink1], [@pone.0031036-BandahRozenfeld1]--[@pone.0031036-Pieras1]. Since the Japanese were divided into small semi-closed population groups among which intercommunication was quite less until the mid-20^th^ century, obvious or latent consanguineous marriages were carried out more frequently, leading to relatively high inbreeding levels in those populations. The frequency of the c.4957_4958insA and c.8868C\>A mutations may result from a founder effect like that of the 2299delG *USH2A* gene mutation, which accounts for 44% of disease alleles in Danish and Norwegian patients with Usher syndrome type II [@pone.0031036-Dreyer1].

We detected 13 different very likely and possible pathogenic mutations. Three were truncating mutations and accounted for 60% (21/35) of mutated alleles. Likewise, previous studies reported that most pathogenic mutations were truncated type (nonsense, deletion, insertion, or splicing) [@pone.0031036-AbdElAziz2]--[@pone.0031036-Littink1], [@pone.0031036-BandahRozenfeld1]--[@pone.0031036-Pieras1]. Furthermore, c.6557G\>A was the only mutation that was common between the Japanese and other populations. This mutation has been found in Korean/American and Chinese patients [@pone.0031036-AbdElAziz2], [@pone.0031036-Littink1]. These results indicate that the *EYS* gene mutation spectrum among Japanese patients largely differs from that among the previously mentioned non-Asian populations. The Japanese and Korean mutation spectrum may resemble each other, but an accurate comparison could not be made, because further *EYS* gene analysis of Korean RP patients is required to clarify this possibility.

A second mutant allele could not be detected by direct sequencing in 17 of 26 patients in our study. Previous studies reported 7 of 10 [@pone.0031036-AbdElAziz2] and 9 of 17 [@pone.0031036-Barragn1] patients with heterozygous *EYS* gene mutation, implying that this finding could be due to relatively large heterozygous deletions [@pone.0031036-Pieras1]. The second mutation in these families may also have been located within the gene regulatory elements or unknown exons including alternative splicing areas. Although rare, a single *EYS* mutation in combination with another mutation on a second gene could also explain this phenotype [@pone.0031036-AbdElAziz2].

The c.4957_4958insA and c.8868C\>A mutations were not detected in Japanese patients with adRP or with LCA. Abd El-Aziz et al. reported that *EYS* gene mutation screening did not reveal any pathogenic mutations in 95 British and Chinese adRP patients [@pone.0031036-AbdElAziz2]. Bandah-Rosenfeld et al. reported that no mutation was found in 2 Oriental Jewish and Israeli Muslim LCA patients who had a large homozygous region harboring the *EYS* gene [@pone.0031036-BandahRozenfeld1]. Although further analysis of all *EYS* gene exons is required, *EYS* gene mutations may not be detected in Japanese patients with adRP and LCA. The c.4957_4958insA and c.8868C\>A mutations were also detected in Korean patients with arRP and accounted for 6.3% (4/64 alleles) of the disease alleles. Similar to Japanese arRP results, the c.4957_4958insA mutation was more frequently detected than the c.8868C\>A mutation. The fact that both c.4957_4958insA and c.8868C\>A mutations were also detected in Korean patients suggests the possibility that the mutations occurred in an ancient common ancestor and spread throughout East Asia.

RP is a highly heterogeneous disease, with a reported prevalence rate of 1 in 4,000--8,000 people in Japan. Given the population of Japan, approximately a 100 million, the number of patients with RP can be estimated to be 12,500--25,000. The relative frequencies of RP inheritance patterns in Japanese patients were estimated as 25.2% for autosomal recessive, 16.9% for autosomal dominant, 1.6% for X-linked, and 56.3% for simplex, indicating that most Japanese RP patients represent arRP or isolated cases [@pone.0031036-Hayakawa1]. Autosomal recessive and simplex cases account over 80% of RP cases in Japan (approximately 10,000--20,000 people). Our results indicate that c.4957_4958insA and c.8868C\>A mutations are possibly present in 1,600--3,200 Japanese patients with RP. These 2 novel mutations will be very useful for genetic diagnosis and counseling, and analysis of the mutated proteins may be helpful in the development of effective therapies for RP in Japan and Korea.

In conclusion, mutation screening of the *EYS* gene in 100 Japanese patients revealed 13 different pathogenic mutations, confirming that the mutation spectrum in Japanese patients differs from the previously reported spectrum in patients of non-Asian populations. Among these 13 mutations, 2 truncating mutations, c.4957_4958insA and c.8868C\>A, were detected in at least one mutated allele in 16% of Japanese arRP patients and may be the most frequent mutations causing RP in the Japanese populations. Screening for c.4957_4958insA and c.8868C\>A mutations in the *EYS* gene is, therefore, very effective for the genetic testing and counseling of RP patients in Japan. Further analysis is necessary to obtain a more precise mutation spectrum and to identify other frequent mutations in other East Asian populations.
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